Practice management in the era of anti-VEGF therapy (Part I)

Article

Identifying the bottlenecks that are preventing effective management of neovascular AMD.

Related Videos
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
Related Content
To Infinity and (PRES)BYOND - The game changer for my practice

To Infinity and (PRES)BYOND - The game changer for my practice

April 4th 2024
Article
Site Logo

Updates From Angiogenesis-2022

February 11th 2022
Podcast
A detective looks through a magnifying glass at an eyeball. Image created with Canva AI.

Hemorrhagic unilateral retinopathy: No proven aetiology for rare condition

April 2nd 2024
Article

Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages

Site Logo

Updates from ASRS 2021

October 28th 2021
Podcast
Glasses with an overlay of digital data outputs on the surface. Image credit: ©Taiwo – stock.adobe.com

Exonate shares results from Phase Ib/IIa trial of EXN407 eye drops for DR and DME

March 27th 2024
Article

In addition to the primary safety and tolerability endpoints, the study also saw signals of biological response from EXN407

Onboarding a new trifocal hydrophobic C-loop IOL My early experiences with AT ELANA® 841P from ZEISS

Onboarding a new trifocal hydrophobic C-loop IOL My early experiences with AT ELANA® 841P from ZEISS

March 22nd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.